Major players in the cardiovascular monitoring and diagnostic devices and equipment market are Medtronic PLC, Boston Scientific Corporation, GE Healthcare, Johnson & Johnson, Philips Healthcare, Siemens Healthcare, St.

New York, May 13, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2022" - https://www.reportlinker.com/p06277203/?utm_source=GNW Jude MedicalInc, Nihon Kohden Corporation, FUKUDA DENSHI Co. Ltd, and Sorin Group. The global cardiovascular monitoring and diagnostic devices and equipment market is expected to grow from $2.83 billion in 2021 to $3.12 billion in 2022 at a compound annual growth rate (CAGR) of 10.2%. The market is expected to grow to $4.34 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The cardiovascular monitoring and diagnostic devices and equipment market consists of sales of cardiovascular monitoring and diagnostic devices and equipment and related services. The main product types of cardiovascular monitoring and diagnostic devices and equipment are cardiopulmonary stress testing systems, ECG data management systems, ECG monitoring equipment, ECG stress testing systems, event monitoring systems, and Holter monitoring systems.ECG monitoring equipment is an electronic device that is used to record the electrical activity of the heart. . The various types involved are heart disease and coronary heart disease. The various end-users involved are hospitals/physician clinics (continuous glucose monitors), home/emergency, and research and development (clinical trials, universities, CRO). North America was the largest region in cardiovascular monitoring and diagnostic devices and equipment market in 2021.Western Europe was the second-largest region incardiovascular monitoring and diagnostic devices and equipment market. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The cardiovascular monitoring and diagnostic devices and equipment market is being driven by an increasing number of people suffering from obesity and diabetes.Risk factors including high blood pressure and high cholesterol are associated with obesity and diabetes leads to cardiovascular diseases. For instance, as per a study conducted by the American Heart Association (AMA), by 2030, 22.2 million CVD is expected to grow. According to another study conducted by AMA in the U.S., 26 million people have been diagnosed with diabetes, and above 9 million further, have the condition but it hasn’t yet been diagnosed. The cardiovascular monitoring and diagnostic devices and equipment market is being restrained by the FDA’s regulatory control over these devices based on the risks associated with this equipment.Cardiovascular monitoring and diagnostic devices fall into the class II category as per the FDA, which includes devices with moderate to high risk associated with usage. The Class II devices are specially controlled with performance standards which provide the manufacturers with performance specifications, postmarket surveillance which monitors the safety of the device after being released in the market, and also other standards like patient registries and special labeling requirements.For instance, Angel medical systems’ implantable cardiac monitor was unanimously rejected by a panel of FDA experts due to unmet performance specifications. ICMs continuously monitor the electrocardiogram (ECG) of the patient to conduct a real-time examination of the heart rhythm, for up to 36 months.ICMs are mostly used in the analysis of transitory symptoms which have an arrhythmic origin, such as unexplained palpitations. For example, in July 2020, Medtronic received U.S. Food and Drug Administration (FDA) clearance and European CE label approval for its Linq II insertable cardiac monitor (ICM) by remote programming, allowing clinicians to optimize device settings without the requirement for patients to return to the hospital. The US FDA has classified cardiovascular monitoring and diagnostic devices into the Class II category, as they have a moderate to high risk associated with usage.Class II devices are bounded by device-specific regulations which include performance standards, premarket data requirements, postmarket surveillance, and labeling requirements associated with device usage. For instance, the labeling should consist of contraindications, adverse reactions, precautions, warnings, and other instructions before the device is released into the market. The countries covered in the cardiovascular monitoring and diagnostic devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. Read the full report: https://www.reportlinker.com/p06277203/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________

What happened Shares of drugmaker Novavax (NASDAQ: NVAX) are up to the tune of 18.9% as of 2:11 p.m. ET Friday, according to data from S&P Global Market Intelligence, thanks to a confluence of events that work in the company's favor.

Whether you're looking for household goods at discounted prices or need to buy your grocery items in bulk, Costco is the go-to retailer for millions of shoppers across the U.S. But despite its ability to attract a loyal following, Costco has made a number of changes recently that haven't thrilled customers. In April, the warehouse retailer got rid of its special COVID hours for seniors, and just this month, Costco ended its mortgage program for members. Now, the retailer has a new warning for sh

Many Americans are surprised to see they have not prepared as well as they had hoped for retirement when they finally get ready to call it quits. The bad news is, you’ll probably have to make some realistic assumptions of what your retirement will look like. If you’ve lived primarily paycheck to paycheck in your working years, that may continue to feel the case in your retirement.

Mirati is unlikely to carve out a share of the lung cancer market, analysts said Friday as MRTX stock collapsed on a testing disappointment.

While the price of gasoline frequently steals all the headlines, the price of diesel is actually more important when it comes to the cost of living and the economy.

Ford has been walloped. But this Wall Street firm says it has the gas to come back strong.

Eli Lilly said Friday it will unveil new test results for its biggest cancer drug, Verzenio, in June and LLY stock broke out to a fresh high.

Billions of dollars have been poured into companies seeking early detection of cancer through common blood draws.

Stock splits have been all the rage in recent years, fueled by surging stock prices of some of the world's most recognizable companies. Worse still, the tech-heavy Nasdaq has tumbled into bear market territory, down roughly 27% from its high reached late last year. Read on to find out why they picked Amazon (NASDAQ: AMZN), Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG), and Shopify (NYSE: SHOP) from among the recent stock-split candidates.

The stocks for companies developing cancer therapies were moving in morning trading on Friday as biotechs and researchers shared new clinical findings in advance of next week’s American Society of Clinical Oncology annual meeting. Arcellx Inc.’s (ACLX) stock jumped 11.9% after an abstract provided updated data for its CART-ddBCMA. SVB Securities analysts said in a note on Friday that they were pleased to see that the experimental therapy “continues to have a competitive efficacy signal in 24 evaluable relapsed/refractory patients.”

When Warren Buffett, the CEO of conglomerate Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B), buys or sells a stock, Wall Street and investors tend to pay close attention. Since taking the reins, Buffett has created close to $670 billion in value for his shareholders (which includes himself), and he's led his company's Class A shares (BRK.A) to an almost unfathomable 20.1% average annual return. To put this performance in another context, the benchmark S&P 500 has "only" gained 30,209%, including dividends paid, since Buffett took over Berkshire Hathaway.

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

Global car production has been hampered for months because of a plethora of supply-chain and logistics issues. Friday, Toyota Motor (ticker: TM) cut its production plans again. Toyota is taking additional downtime at some plants the week of June 6.

The departure comes as the electric-truck startup is under pressure to overcome supply-chain problems that led the company to lower its production forecast for the year.

Retirement savers are often told they’ll see a greater return in their retirement assets if they invest it – and that may be true – but it’s important to prioritize some cash in a retirement plan as well. Retirement Tip of the Week: For those close to retirement, consider keeping a portion of your retirement plan in cash – whether that be in the portfolio itself, or in a separate account. Bank and money market accounts do not generate the same type of returns as investments, though right now with volatility some investors may beg to differ.

Under-the-radar commodity traders are cashing in on Russian oil, stepping in to buy and transport crude to customers as their bigger rivals retreat from the market.

JPMorgan expects fewer iPhone 14 units to be built in 2022 than the previous iPhone 13 model built in 2021.

This is also a good time to examine your investment portfolio. Procter & Gamble (NYSE: PG) sells basic items that people use regularly, no matter what's happening in the economy. For the fiscal third quarter (ended March 31), Procter & Gamble's sales, excluding foreign currency translations, rose by 10%, with price increases accounting for 5% and increased volume responsible for 3% (a change in mix represented the balance).

If you regularly reach for seed oils like canola oil, sesame oil or grapeseed oil when cooking -- or buy packaged foods that contain them -- listen up.

The first flight of the B-21 bomber, one of Wichita-based Spirit AeroSystems Inc.’s most important defense programs, has been moved back to 2023. The Northrop Grumman B-21 had previously been expected to fly later this year. According to a report from the Air Force Times, the service pushed back first flight by at least six months but is still expected to publicly unveil the first aircraft later this year.